Impact of Na+/glucose cotransporter 2 (SGLT2) inhibitor therapy on biventricular ventricular-arterial coupling in patients with heart failure with reduced ejection fraction

29 August 2025 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Targeting metabolism in heart failure Heart Failure with Reduced Ejection Fraction (HFrEF) ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology